share_log

3: Initial statement of beneficial ownership of securities-Officer Shah Vinay

3: Initial statement of beneficial ownership of securities-Officer Shah Vinay

3:首次持股声明-高管 Shah Vinay
美股SEC公告 ·  2024/11/19 05:05

Moomoo AI 已提取核心信息

Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 11/16/2024, indicates that Shah does not beneficially own any securities in the company. The filing, which is a standard regulatory requirement for officers, directors, and 10% owners, provides transparency about the holdings of company insiders. Shah's filing was completed on 11/18/2024 and is part of the compliance with Section 16(a) of the Securities Exchange Act of 1934.
Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 11/16/2024, indicates that Shah does not beneficially own any securities in the company. The filing, which is a standard regulatory requirement for officers, directors, and 10% owners, provides transparency about the holdings of company insiders. Shah's filing was completed on 11/18/2024 and is part of the compliance with Section 16(a) of the Securities Exchange Act of 1934.
adial pharmaceuticals的首席财务官Vinay Shah已根据Form 3的要求向SEC提交了一份持有证券的初步受益所有权声明。这份日期为2024年11月16日的文件显示,Shah并未实际持有公司的任何证券。这一申报是公司高管、董事和持有公司10%以上股份者的标准监管要求,为公开公司内部人员的持股提供透明度。Shah的申报已于2024年11月18日完成,属于《证券交易法1934年第16(a)条》的合规要求之一。
adial pharmaceuticals的首席财务官Vinay Shah已根据Form 3的要求向SEC提交了一份持有证券的初步受益所有权声明。这份日期为2024年11月16日的文件显示,Shah并未实际持有公司的任何证券。这一申报是公司高管、董事和持有公司10%以上股份者的标准监管要求,为公开公司内部人员的持股提供透明度。Shah的申报已于2024年11月18日完成,属于《证券交易法1934年第16(a)条》的合规要求之一。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息